Journal: bioRxiv
Article Title: Sex- and hepatocyte PPARγ-dependent effects of an obesogenic dietary approach to induce MASH with fibrosis in mice
doi: 10.64898/2026.02.25.707976
Figure Lengend Snippet: Liver weight (A), liver TG content (B), liver cholesterol content (C), plasma ALT level (D), MASLD activity score (E), and picrosirius red-stained fibrotic area (F) of mice in cohorts #1 [LF, HF, and HFCF-fed mice] and #2 [LF, HF, and HFC+Fr-fed mice]. Representative pictures of hematoxylin & eosin (H&E)- and picrosirius red/fast green (SR/FG)-stained liver section of mice in cohort #1 (G, LF, HF, and HFCF-fed mice) and cohort #2 (H, LF, HF, and HFC+Fr-fed mice). Hepatic gene expression of Pparg (I), Cidec (J), Col1a1 (K), Timp1 (L), Tnfa (M), Ccl2 (N), Trem2 (O), Gnmt (P), Pemt (Q), and Bhmt (R) of mice in cohort #1 (HF, and HFCF-fed mice) and cohort #2 (HF, and HFC+Fr-fed mice). I-R, expression level is represented as relative values of HF-fed control mice in cohort #1 or coho rt #2. Data are shown as mean ± standard error of the mean (SEM). Letters (a-d) indicate significant differences between LF-fed and HF-fed control mice. Exclamation marks (!) indicate significant differences between HF-fed and HFCF-control mice in Cohort #1 or HF-fed and HFC+Fr-control mice in Cohort #2. Plus signs (+) indicate significant differences between HF-fed and HFCF- Pparg ΔHep mice in Cohort #1 or HF-fed and HFC+Fr- Pparg ΔHep mice in Cohort #2. Asterisks indicate significant differences between control and Pparg ΔHep mice. a, !, * p<0.05; b, !!, ++, ** p<0.01; !!!,+++, *** p<0.001; d, !!!!, ++++, ****, p<0.0001. n= 5-11 mice/group in cohort #1 and 7-8 mice/group in cohort #2.
Article Snippet: Then, ponceau S stain was removed, and the membranes were incubated in the blocking buffer: 5% non-fat dry milk in Tris-buffered saline with 0.1% Tween-20 (TBST) for one hour at room temperature, and incubated at 4°C overnight with either PPARγ (1:500, C26H12, Cell Signaling Technologies, Danvers, MA, USA), COL1A1 (1:1000, E8F4L, Cell Signaling Technologies,), CIDEC (1:500, NB100-430,Novus Biologicals, Centennial, CO), BHMT (1:10000, ab96415, Abcam, Waltham, MA).
Techniques: Clinical Proteomics, Activity Assay, Staining, Gene Expression, Expressing, Control